FIELD: medicine, oncology, biochemistry.
SUBSTANCE: invention can be used for complex diagnosis of cancer endometrium. Method involves determination of total activity of alkaline phosphatase in aspirates obtained from uterus cavity. Cancer endometrium is diagnosed if the level of its activity is above 80 U/l in combination with results of cytological analysis. Method provides enhancing precision of diagnosis and reducing traumatism.
EFFECT: improved diagnosis method.
3 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF DIAGNOSING HYPERPLASTIC PROCESSES AND ENDOMETRIUM CANCER | 1995 |
|
RU2127429C1 |
METHOD FOR ESTIMATING ENDOMETRIUM CONDITION IN FEMALE GENITALIA NEOPLASM CASES | 2005 |
|
RU2290639C1 |
METHOD OF HYPERPLASTIC ENDOMETRIUM PROCESSES DIAGNOSTICS AT HYSTEROMYOMA | 2007 |
|
RU2327164C1 |
METHOD FOR DIAGNOSTICS OF ENDOMETRIUM PATHOLOGY IN PATIENTS WITH HYSTEROMYOMA | 2007 |
|
RU2334987C1 |
METHOD OF DIFFERENTIAL DIAGNOSTICS OF HIGHLY DIFFERENTIATED ENDOMETRIOID ADENOCARCINOMA OF CORPUS UTERI IN PATIENTS OF PERIMENOPAUSAL PERIOD | 2014 |
|
RU2561677C1 |
DIAGNOSTIC TECHNIQUE FOR ATYPICAL ENDOMETRIAL HYPERPLASIA | 2010 |
|
RU2424518C1 |
METHOD FOR PREDICTING HYPERPLASTIC ENDOMETRIAL PROCESS | 2005 |
|
RU2295917C1 |
METHOD FOR TREATING HYPERPLASTIC PROCESSES IN ENDOMETRIUM | 2001 |
|
RU2214823C2 |
METHOD FOR DIAGNOSING THE CASES OF GLAND CYST HYPERPLASIA | 2000 |
|
RU2199741C2 |
METHOD FOR DETERMINING HYSTERECTOMY INDICATIONS IN ENDOMETRIUM HYPERPLASIA CASES | 2006 |
|
RU2310857C1 |
Authors
Dates
2004-07-10—Published
2002-04-03—Filed